Global /Brazil /Healthcare /Pharmaceutical Retailers /RADL3
chevron_leftBack

Raia Drogasil S.A.

RADL3
BVMF: RADL3 Delayed
20.37BRL 1.1%
3.55 USD
As of 24 April 2025, Raia Drogasil S.A. has a market cap of $6.07B USD, ranking #2477 globally and #28 in Brazil. It ranks #210 in the Healthcare sector, and #5 in the Pharmaceutical Retailers industry.
Global Rank
2477
Country Rank
28
Sector Rank
210
Industry Rank
5
Key Stats
Market Cap
$6.07BUSD
34.87B BRL
Enterprise Value
$7.32BUSD
42.06B BRL
Revenue (TTM)
$6.77BUSD
38.86B BRL
EBITDA (TTM)
$532.87MUSD
3.06B BRL
Net Income (TTM)
$208.49MUSD
1.2B BRL
EBITDA Margin
7.9%
Profit Margin
3.1%
PE Ratio
28.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Pharmaceutical Retailers
CEO
Renato Raduan open_in_new
Employees
64,758
Founded
1905
Website
rdsaude.com.br open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.1% -11% 3.3% -2.2% -19% -19%
Upcoming Earnings
Earnings Date
Tue, May 6

Markets

Exchange Ticker Price
Brazil Stock Exchange (B3)
MIC: BVMF
PRIMARY
RADL3
Raia Drogasil SA
ISIN: BRRADLACNOR0
Shares Out.:
1.712B1 Shares Float: 1.287B2
TV:
SA:
YF:
GF:
BA:
MS:
20.37 BRL
OTC Markets
MIC: OTCM
RADLY
Raia Drogasil SA ADR
ISIN: US7507231089
TV:
SA:
YF:
GF:
BA:
MS:
3.57 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Raia Drogasil S.A.

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Similar Companies

Industry: Pharmaceutical Retailers (Brazil)
Name
Market Cap diff.
Empreendimentos Pague Menos S.A.
PGMN3
$330.23M
1.9B BRL
-95%
d1000 Varejo Farma Participações S.A.
DMVF3
$58.76M
337.52M BRL
-99%
Industry: Pharmaceutical Retailers (Global)
Name
Market Cap diff.
JD Health International Inc.
6618
$14.9B
115.59B HKD
145%
Alibaba Health Information Technology Ltd.
241
$9.83B
76.23B HKD
62%
Walgreens Boots Alliance, Inc.
WBA
$9.5B
57%
MatsukiyoCocokara & Co.
3088
$7.63B
1.09T JPY
26%
COSMOS Pharmaceutical Corp.
3349
$5.01B
713.32B JPY
-18%